Literature DB >> 24776488

Individual differences in risk-related behaviors and voluntary alcohol intake in outbred Wistar rats.

Shima Momeni1, Mana Sharif, Greta Agren, Erika Roman.   

Abstract

Some personality traits and comorbid psychiatric diseases are linked to a propensity for excessive alcohol drinking. The objective of this study was to investigate the association between individual differences in risk-related behaviors, voluntary alcohol intake and preference. Outbred male Wistar rats were tested in a novel open field, followed by assessment of behavioral profiles using the multivariate concentric square field (MCSF) test. Animals were classified into high risk taking and low risk taking on the basis of open-field behavior and into high risk-assessing (HRA) and low risk-assessing (LRA) on the basis of the MCSF profile. Finally, voluntary alcohol intake was investigated using intermittent access to 20% ethanol and water for 5 weeks. Only minor differences in voluntary alcohol intake were found between high risk taking and low risk taking. Differences between HRA and LRA rats were more evident, with higher intake and increased intake over time in HRA relative to LRA rats. Thus, individual differences in risk-assessment behavior showed greater differences in voluntary alcohol intake than risk taking. The findings may relate to human constructs of decision-making and risk taking associated with a predisposition to rewarding and addictive behaviors. Further studies are needed to clarify the relationship between risk-related behaviors, including risk-assessment behavior, and liability for excessive alcohol intake.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24776488     DOI: 10.1097/FBP.0000000000000036

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  8 in total

1.  Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.

Authors:  David E Moorman; Morgan H James; Elisabeth A Kilroy; Gary Aston-Jones
Journal:  Brain Res       Date:  2016-10-19       Impact factor: 3.252

2.  SLC38A10 Knockout Mice Display a Decreased Body Weight and an Increased Risk-Taking Behavior in the Open Field Test.

Authors:  Frida A Lindberg; Karin Nordenankar; Robert Fredriksson
Journal:  Front Behav Neurosci       Date:  2022-05-23       Impact factor: 3.617

3.  Intermittent Access to Ethanol Drinking Facilitates the Transition to Excessive Drinking After Chronic Intermittent Ethanol Vapor Exposure.

Authors:  Adam Kimbrough; Sarah Kim; Maury Cole; Molly Brennan; Olivier George
Journal:  Alcohol Clin Exp Res       Date:  2017-07-05       Impact factor: 3.455

4.  Response: Commentary: Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats.

Authors:  Lova Segerström; Erika Roman
Journal:  Front Neurosci       Date:  2016-09-30       Impact factor: 4.677

5.  The zebrafish Multivariate Concentric Square Field: A Standardized Test for Behavioral Profiling of Zebrafish (Danio rerio).

Authors:  Laura E Vossen; Ronja Brunberg; Pontus Rådén; Svante Winberg; Erika Roman
Journal:  Front Behav Neurosci       Date:  2022-03-17       Impact factor: 3.558

6.  Age-Dependent Behavioral and Metabolic Assessment of App NL-G-F/NL-G-F Knock-in (KI) Mice.

Authors:  Shanshan Wang; Taiga Ichinomiya; Paul Savchenko; Swetha Devulapalli; Dongsheng Wang; Gianna Beltz; Takashi Saito; Takaomi C Saido; Steve L Wagner; Hemal H Patel; Brian P Head
Journal:  Front Mol Neurosci       Date:  2022-07-29       Impact factor: 6.261

7.  Risk-assessment and risk-taking behavior predict potassium- and amphetamine-induced dopamine response in the dorsal striatum of rats.

Authors:  Sara Palm; Shima Momeni; Stina Lundberg; Ingrid Nylander; Erika Roman
Journal:  Front Behav Neurosci       Date:  2014-07-15       Impact factor: 3.558

8.  Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats.

Authors:  Shima Momeni; Lova Segerström; Erika Roman
Journal:  Front Neurosci       Date:  2015-11-05       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.